SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

CORT.O (CORT.O) News

Track canonical SquawkNews coverage tagged to CORT.O, CORT.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CORT.O Asset market Sector Markets 90 days 1 Updated Sep 18, 2026, 12:04 PM UTC Open live news feed
L Corcept says EU CHMP backs Lifyorli combo for platinum — resistant ovarian cancer EU drug regulator’s CHMP backed marketing authorization for Corcept’s Lifyorli (relacorilant) with nab-paclitaxel in platinum-resistant ovarian cancer. Recommendation cited Phase 2 and Phase 3 ROSELLA data showing longer REGULATION | Sep 18, 2026, 12:04 PM UTC